Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
08 Aug 2024
Historique:
received: 18 04 2024
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2024.285707 PMID: 39113654
pubmed: 39113654
doi: 10.3324/haematol.2024.285707
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Farnaz Barneh (F)

Princess Máxima Center for Pediatric Oncology, Utrecht.

Joost B Koedijk (JB)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus MC-Sophia Children's Hospital, Department of Pediatric Oncology, Rotterdam.

Noa E Wijnen (NE)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Department of Pediatric Oncology, Amsterdam.

Tom Meulendijks (T)

Princess Máxima Center for Pediatric Oncology, Utrecht.

Minoo Ashtiani (M)

Princess Máxima Center for Pediatric Oncology, Utrecht.

Ester Dunnebach (E)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.

Noël Dautzenberg (N)

Princess Máxima Center for Pediatric Oncology, Utrecht.

Annelisa M Cornel (AM)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.

Anja Krippner-Heidenreich (A)

Princess Máxima Center for Pediatric Oncology, Utrecht.

Kim Klein (K)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Wilhelmina Children's Hospital/University Medical Center, Utrecht.

Michel C Zwaan (MC)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus MC-Sophia Children's Hospital, Department of Pediatric Oncology, Rotterdam.

Jürgen Kuball (J)

Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.

Stefan Nierkens (S)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht.

Jacqueline Cloos (J)

Department of Hematology, Amsterdam UMC, Location VUMC, Cancer Center Amsterdam.

Gertjan J L Kaspers (GJL)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Department of Pediatric Oncology, Amsterdam. g.j.l.kaspers@prinsesmaximacentrum.nl.

Olaf Heidenreich (O)

Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom; University Medical Center Utrecht, Utrecht University, Utrecht. O.T.Heidenreich@prinsesmaximacentrum.nl.

Classifications MeSH